AMETEK, Inc. (NYSE:AME) Q4 2023 Earnings Call Transcript

David Zapico: Yes. The process is a broader look at our process and analytical instruments business and the specific process industry would be more the process and analytical instruments business, which is a good part of it. And I think that what you’re going to see there is our energy businesses are perhaps — they grew nicely in Q4, and they have a good outlook for 2024. I think we sell a lot of business to Asia and China is a — I told you we talked about it being flat. So that’s something that we’re concerned within the year for process. But as long as we keep developing state-of-the-art projects that are unmatched by our competitors, we’re going to be fine in process. And as evidenced by our CAMECA, Zygo, broader UPT, broader MAD sales.

So it’s the research market. It’s the optics market that are driving the business, and there are some medical applications in our rolling business that are in that segment. So there’s a mix of different end market drivers. But when you look at the thing in total, we’re calling it up low single digits this year. And again, the international parts of the business will be weaker than the U.S. parts.

Operator: And I’m showing no further questions. I would now like to turn the conference back to Kevin Coleman for closing remarks.

Kevin Coleman: Thank you again, Tanya, and thank you, everyone, for joining us for the conference call today. And as a reminder, a replay of the webcast can be accessed in the Investors section of ametek.com. Have a great day.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.